Valuation: Stem Cells Spin S.A.

Market Cap	20.09M 5.38M 4.64M 4.37M 3.97M 7.47M 515M 7.58M 51.26M 258M 20.19M 19.75M 858M	P/E 2024	-15.6x	P/E 2025	-31.9x
Enterprise Value	20.17M 5.4M 4.66M 4.39M 3.99M 7.5M 517M 7.61M 51.48M 259M 20.28M 19.84M 862M	EV / Sales 2024	151x	EV / Sales 2025	257x
Free-Float	19.04%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Stem Cells Spin S.A.

08-14	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-15	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
11-13	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/05/25	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
13/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
13/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	CI
14/08/24	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
15/05/24	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
14/11/23	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

More news

Managers and Directors: Stem Cells Spin S.A.

Manager	Title	Age	Since
Adam Symber CEO	Chief Executive Officer	45	31/12/2016

Director	Title	Age	Since
Marek Andrzej Cegielski BRD	Director/Board Member	74	27/06/2022
Andrzej Jan Trznadel BRD	Director/Board Member	64	-
Piotr Okoniewski BRD	Director/Board Member	-	14/03/2022

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STEM CELLS SPIN S.A.	+1.25%	+10.45%	+32.79%	+27.89%	5.38M
LONZA GROUP AG	+0.49%	+0.18%	+1.25%	+20.71%	48.63B
REVOLUTION MEDICINES, INC.	+1.89%	+5.08%	+492.59%	+629.24%	46.3B
BEONE MEDICINES AG	+1.83%	+2.75%	+15.61%	+91.22%	41.97B
IQVIA HOLDINGS INC.	-0.50%	-1.56%	+24.67%	+12.17%	39.51B
CELLTRION, INC.	-2.74%	-7.13%	+18.72%	+49.04%	31.75B
MEDPACE HOLDINGS, INC.	-1.14%	-2.51%	+27.52%	+136.42%	16.48B
ASCENDIS PHARMA A/S	+0.59%	-2.25%	-	-	16.34B
EUROFINS SCIENTIFIC SE	-0.17%	-0.09%	+2.57%	+29.35%	14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-2.60%	-1.00%	+77.85%	+40.37%	13.33B
Average	-0.11%	-0.06%	+77.06%	+115.16%	26.83B
Weighted average by Cap.	+0.13%	-0.43%	+105.64%	+155.59%

See all sector performances

Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

Employees

Sector

Biotechnology & Medical Research

Calendar

11-16 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
18/08/26	PLN 0.4860	+1.25%	1,251
17/08/26	PLN 0.4800	+0.42%	10
14/08/26	PLN 0.4780	+8.64%	2,334
11/08/26	PLN 0.4400	-2.22%	233

End-of-day quote Warsaw S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Warsaw S.E. 18/08/2026			5-day change	1st Jan Change
0.4860 ^PLN	+1.25%		+10.45%	+19.70%

1 day	+1.25%
1 week	+10.45%
Current month	-0.82%
1 month	-2.80%
3 months	+10.45%
6 months	+23.98%
Current year	+19.70%

1 week	0.45	0.49
1 month	0.4	0.54
Current year	0.33	0.54
1 year	0.28	0.54
3 years	0.14	0.82
5 years	0.14	1.12
10 years	0.14	2.04

	2024	2025
Net sales	54.28K 14.53K 12.55K 11.81K 10.73K 20.18K 1.39M 20.48K 139K 696K 54.55K 53.37K 2.32M	65.74K 17.6K 15.2K 14.3K 13K 24.44K 1.69M 24.8K 168K 843K 66.07K 64.63K 2.81M
Net income	-520K -139K -120K -113K -103K -193K -13.34M -196K -1.33M -6.67M -523K -512K -22.23M	-526K -141K -122K -114K -104K -195K -13.48M -198K -1.34M -6.74M -528K -517K -22.46M
Net Debt	69.28K 18.55K 16.02K 15.07K 13.7K 25.76K 1.78M 26.14K 177K 889K 69.63K 68.12K 2.96M	84.58K 22.64K 19.56K 18.4K 16.72K 31.45K 2.17M 31.91K 216K 1.09M 85.01K 83.17K 3.61M

Stem Cells Spin S.A. Share Price

Stocks

SCS

PLSTCLS00013

Biotechnology & Medical Research

Valuation: Stem Cells Spin S.A.

Chart: Stem Cells Spin S.A.

Latest news : Stem Cells Spin S.A.

Quotes and Performance

Course Extremes

Managers and Directors: Stem Cells Spin S.A.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates